151 related articles for article (PubMed ID: 1672634)
21. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
[TBL] [Abstract][Full Text] [Related]
22. [A comparison of bronchodilating drugs in the treatment of stable COPD].
Nishimura K; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
[TBL] [Abstract][Full Text] [Related]
23. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
[TBL] [Abstract][Full Text] [Related]
24. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
Nishimura K; Koyama H; Ikeda A; Izumi T
Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
[TBL] [Abstract][Full Text] [Related]
25. Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction.
Berger R; Smith D
Am Rev Respir Dis; 1988 Sep; 138(3):624-9. PubMed ID: 3202416
[TBL] [Abstract][Full Text] [Related]
26. Effects of high-dose ipratropium bromide and oral aminophylline on spirometry and exercise tolerance in COPD.
Shivaram U; Cash ME; Mateo F; Shim C
Respir Med; 1997 Jul; 91(6):327-34. PubMed ID: 9282234
[TBL] [Abstract][Full Text] [Related]
27. Comparison of bronchodilator effects of Duovent and Reproterol in patients with chronic reversible airway obstruction.
Baronti A; Grieco A; Lelli M; Virgili G
Respiration; 1986; 50 Suppl 2():173-6. PubMed ID: 2951800
[TBL] [Abstract][Full Text] [Related]
28. Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury.
DeLuca RV; Grimm DR; Lesser M; Bauman WA; Almenoff PL
Chest; 1999 Jun; 115(6):1533-8. PubMed ID: 10378545
[TBL] [Abstract][Full Text] [Related]
29. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Ikeda A; Nishimura K; Koyama H; Izumi T
Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
[TBL] [Abstract][Full Text] [Related]
30. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
Nannini LJ
Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
[TBL] [Abstract][Full Text] [Related]
31. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
[TBL] [Abstract][Full Text] [Related]
32. [Bronchodilatation and anticholinergic agents].
Tschopp JM
Schweiz Rundsch Med Prax; 1990 May; 79(22):698-9. PubMed ID: 1971962
[TBL] [Abstract][Full Text] [Related]
33. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
[TBL] [Abstract][Full Text] [Related]
34. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
[TBL] [Abstract][Full Text] [Related]
35. Use of ipratropium bromide in asthma. Results of a multi-clinic study.
Storms WW; Bodman SF; Nathan RA; Busse WW; Bush RK; Falliers CJ; O'Hollaren JD; Weg JG
Am J Med; 1986 Nov; 81(5A):61-6. PubMed ID: 2947462
[TBL] [Abstract][Full Text] [Related]
36. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease.
RodrÃguez-Carballeira M; Heredia JL; Gomez L; Quintana S; Vinas C
Pulm Pharmacol Ther; 1999; 12(1):43-8. PubMed ID: 10447370
[TBL] [Abstract][Full Text] [Related]
37. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
38. Comparison of a B2 adrenergic agonist and an anticholinergic agent given by sequential inhalation in patients with severe chronic obstructive pulmonary disease.
Heimer D; Brami JL; Liberman D; Bark H
Isr J Med Sci; 1991 Jun; 27(6):307-10. PubMed ID: 1676394
[TBL] [Abstract][Full Text] [Related]
39. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
Patrick DM; Dales RE; Stark RM; Laliberte G; Dickinson G
Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
[TBL] [Abstract][Full Text] [Related]
40. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.
Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W
Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
